EUVIMEDEUVIMED entdecken
Crossref

Pediatric Immune Thrombocytopenia: Advances in Pathophysiology, Diagnosis, Risk-Based Management, and Emerging Therapeutic Strategies

Muktarali kyzy Begimai, Pallavi Kumari, Rajpriya Deo, Sadia Jamal, Samreen Rashid

International Journal of Sciences and Innovation Engineering · 04.11.2026 · 3 (11) · 247-252

DOI: 10.70849/ijsci03112681242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Sciences and Innovation Engineering, online erschienen am 04.11.2026. Verfasst von Muktarali kyzy Begimai und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pediatric immune thrombocytopenia (ITP) is an acquired autoimmune bleeding disorder characterized by isolated thrombocytopenia resulting from a combination of autoantibody-mediated platelet destruction and impaired thrombopoiesis. While the majority of children experience a self-limiting acute course that resolves within months, a substantial minority progress to persistent or chronic disease.

Objective

This narrative review aims to synthesize contemporary clinical insights, foundational mechanisms, diagnostic pathways, risk-based management strategies, and emerging therapeutic innovations for pediatric ITP.

Conclusion

Management of pediatric ITP has shifted away from aggressive interventions toward a bleeding-centric, risk-adapted approach. The advent of thrombopoietin receptor agonists (TPO-RAs) and novel immunomodulatory strategies has profoundly expanded therapeutic options for refractory cases, minimizing long-term morbidity.

Zitieren

APA

Begimai, M. K., Kumari, P., Deo, R., Jamal, S., & Rashid, S. (2026). Pediatric Immune Thrombocytopenia: Advances in Pathophysiology, Diagnosis, Risk-Based Management, and Emerging Therapeutic Strategies. International Journal of Sciences and Innovation Engineering, 3(11), 247-252. https://doi.org/10.70849/ijsci03112681242

Vancouver

Begimai MK, Kumari P, Deo R, Jamal S, Rashid S. Pediatric Immune Thrombocytopenia: Advances in Pathophysiology, Diagnosis, Risk-Based Management, and Emerging Therapeutic Strategies. International Journal of Sciences and Innovation Engineering. 2026;3(11):247-252. doi:10.70849/ijsci03112681242

BibTeX
@article{Begimai2026,
  author = {Begimai, Muktarali kyzy and Kumari, Pallavi and Deo, Rajpriya and Jamal, Sadia and Rashid, Samreen},
  title = {Pediatric Immune Thrombocytopenia: Advances in Pathophysiology, Diagnosis, Risk-Based Management, and Emerging Therapeutic Strategies},
  journal = {International Journal of Sciences and Innovation Engineering},
  year = {2026},
  volume = {3},
  number = {11},
  pages = {247--252},
  doi = {10.70849/ijsci03112681242}
}
Kostenlos starten →